According to the findings of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Centre, adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not improve outcomes in patients with differ
Washington D.C. [USA], Jan 29 (ANI): According to an evidence review led by researchers, radioactive iodine is to be recommended as the frontline treatment for patients with thyroid gland overactivity caused by conditions such as Graves' disease.
Oslo [Norway], Oct. 25 (ANI): A nuclear research reactor in southern Norway has experienced an accidental release of small amount of radioactive iodine due to a technical failure, however, the situation is under control, said the authorities on Tuesday.